About us
Protecting our tomorrow
A firm focus on vaccines stands at the core of everything we do.
READ MORE
Our strategy
Our Leadership Team
Executive Management
Board of Directors

Governance
Articles of Association
Board Practices
Policies
Remuneration Reports

Business Ethics
Code of Conduct
Ethics Hotline
Responsible Sourcing
Sustainability
Sustainability Reports
Recognitions
What we do
From R&D to manufacturing
We are focused on the research, development and manufacturing of innovative life-saving vaccines
READ MORE
Products

Pipeline
Chikungunya
Equine encephalitis
Immuno-oncology

Technology
INVESTORS
Investors
We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read more
News
Subscribe
Events & Presentations
Financials

Stock information
Stock Chart
Analysts
Ownership
ADR Program

Annual Report 2022
Annual General Meeting
Shareholder Portal
FAQ
IR Policy
Careers
Careers
We offer a challenging international working environment in which job satisfaction and personal growth have a high priority.
READ MORE
Working With Us
Our Culture
Diversity and Inclusion

Our Employees

Job Openings
Our Recruitment Process

Financial Reports

Download our annual and interim financial reports here.

Interim Results (Q2) as of 30 June 2023

August 23, 2023

English version (pdf)
Spreadsheet (xls)

Interim Results (Q1) as of 31 March 2023

May 9, 2023

English version (pdf)
Spreadsheet (xls)

Annual Report 2022

March 2, 2023

English version (pdf)
Spreadsheet (xls)

Interim Results (Q3) as of 30 September 2022

November 9, 2022

English version (pdf)
Spreadsheet (xls)

Interim Results (Q2) as of 30 June 2022

August 24, 2022

English version (pdf)
Spreadsheet (xls)

Interim Results (Q1) as of 31 March 2022

May 9, 2022

English version (pdf)
Spreadsheet (xls)

Annual Report 2021

March 4, 2022

English version (pdf)
Spreadsheet (xls)

Interim Results (Q3) as of 30 September 2021

November 12, 2021

English version (pdf)
Spreadsheet (xls)

Interim Results (Q2) as of 30 June 2021

August 25, 2021

English version (pdf)
Spreadsheet (xls)

Interim Results (Q1) as of 31 March 2021

May 27, 2021

English version (pdf)
Spreadsheet (xls)